Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Osteoporosis Dx Firm Osteolabs Inks Commercialization Deals in Germany, Turkey

Osteoporosis Dx Firm Osteolabs Inks Commercialization Deals in Germany, Turkey

Jan 20, 2020
|
staff reporter

NEW YORK – German startup Osteolabs announced on Monday its first commercialization agreements covering Germany and Turkey.

In Germany, Osteolabs has signed a deal with Eurofins LifeCodexx to commercialize Osteolabs' diagnostic test for the early detection of osteoporosis. The company has reached a similar deal in Turkey with BioGen Medical.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Business News

  1. Guardant Health Q4 Revenues Up 25 Percent

  2. Kaya 17 Gets CE Mark for Point-of-Care Coronavirus Antigen Test

  3. BioMérieux Reports 21 Percent Revenue Growth in Q4

  4. Biocartis Reports 15 Percent Rise in 2020 Revenues

  5. CareDx Q4 Revenues Up 64 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.